Research Triangle Park-based medical device company TransEnterix (NYSE MKT: TRXC) reported third quarter results earlier this week, highlighting revenue from the first sale of its recently acquired Senhance Surgical Robot System and a new distribution agreement for the device abroad.
TransEnterix reported revenue of $1.5 million for the third quarter of 2016, which the company said represented one Senhance sale, net of deferred revenue. It also announced a new distribution agreement for the device…
Research Triangle Park-based medical device company TransEnterix (NYSE MKT: TRXC) reported third quarter results earlier this week, highlighting revenue from the first sale of its recently acquired Senhance Surgical Robot System and a new distribution agreement for the device abroad.
TransEnterix reported revenue of $1.5 million for the third quarter of 2016, which the company said represented one Senhance sale, net of deferred revenue. It also announced a new distribution agreement for the device…